Under Trump, Antitrust Regulators May Be More Divestiture Friendly

Jul 11
Jul 11, 2025

While President Donald Trump has enacted or proposed numerous policy changes since beginning his second term in January, his administration has kept most of the health care antitrust rules in place, according to speakers at a July 9 Manatt, Phelps & Phillips LLP webinar.

Dylan Carson, a Manatt partner and former Department of Justice (DOJ) attorney, said that “by all appearances, antitrust enforcement in health care remains a high priority.” Still, Manatt experts suggested that this administration may be slightly more open to the idea of divestitures as a remedy for antitrust concerns than the previous administration.
Read more
© 2025 MMIT

Tim Casey

Tim has been a reporter and editor for newspapers, websites and magazines for more than 20 years, including 10 years covering health care business topics. He has a deep knowledge of the managed care industry and pharmacy benefit management. He also has experience covering medical conferences and clinical and legislative health care issues. In 2014, the Society for Advancing Business Editing and Writing selected Tim as one of 15 journalists to participate in a national symposium on the Affordable Care Act. Tim has a B.A. in Psychology from the University of Notre Dame and an M.B.A. from Georgetown University.